Industries

Pharma

Solutions designed for growth

As your partner, Alira Health can help you navigate today’s evolving pharmaceutical industry. With an increased focus on personalized care, the current pharma landscape has a wider range of clusters, each with smaller patient pools. Your dedicated Alira Health team will work closely with you to identify the short- and long-term impacts to your goals, and create tailored solutions.
  • Research and development expenditures
  • Supply chain capacities
  • Pricing strategies

Why choose Alira Health?

As your partner, we’ll work closely with you to uncover opportunities across the pharma industry, accelerate innovation, and deliver tomorrow’s standard of care. You’ll benefit from our:

  • 360° lifecycle approach

    that supports products, technologies, and services from concept ideation to creation and commercialization

  • Regulatory

    clinical, and health expertise in medical affairs strategy and execution

  • Management consulting

    to define growth initiatives and accelerate market penetration. Learn more

  • Global transaction advisory services

    including M&A, licensing, partnering and distribution, and capital raises. Learn more

  • In-depth experience

    across the entire healthcare ecosystem—suppliers, payers, providers, and patients

  • Fully collaborative team

    of bankers, scientists, strategists, and doctors who deliver a holistic view of each project

Areas of expertise

Alira Health teams bring together top talent from every life science and healthcare sector to take your innovation from strategy to reality. Our teams specialize in:
  • Central nervous system
  • Metabolic diseases
  • Oncology
  • Rare and orphan diseases
  • Infectious diseases
  • Dermatology
  • Genetic diseases
  • Addiction diseases
  • Hematology

Local insights, global reach

Since 1999, Alira Health has increased value for its pharma, biotech, and MedTech clients around the world. Our local presence and global collaboration combined with our deep domain experience allows us to deliver actionable insights.
20+
Years serving pharma and MedTech clients
75%
Of the top 50 pharma companies are advised by Alira Health

Working together to humanize healthcare

As your industry evolves, we’re ready to help you lead the way.

Contact us
Gabriele Brambilla
Gabriele Brambilla
Chief Executive Officer
Our clients are disrupting healthcare—they are pioneering new standards of care, and we are their accelerator.

Explore our related publications:

Blog November 17, 2023
Misconceptions About Patient-Centric Co-Design
Many people have misconceptions about patient-centric co-design, and these misconceptions are holding companies back.
Co-Design Digital Health MedTech Patient Centricity Pharma
Blog November 2, 2023
The Impact of New Treatment Approvals in Oncology on Relative Survival Rates for EU Patients
This article explores the relationship between the number of new cancer treatment approvals and the five-year relative survival of cancer patients across the European Union (EU).
Oncology Pharma
Blog October 16, 2023
How to Co-Design a Solution with Patients to Meet Their Needs
To learn how you can benefit from a co-design approach and how to get started, we spoke with two experts on patient engagement and co-design.
Digital Health MedTech Patient Centricity Patient Engagement Pharma
Blog October 9, 2023
Inflation Reduction Act and Pharma – Navigating Uncertainty
What's the impact of the Inflation Reduction Act on small biotechs, mid-size companies and large pharma players, and how can they prepare?
Biotech Pharma
Publications September 19, 2023
Opportunities and Challenges in the Therapeutic and CDMO Markets
Our Transaction Advisory experts have analyzed the CDMO industry trends, M&A activities, and projected growth in this CHEManager article.
CDMO Pharma
News August 31, 2023
Alira Health Named One of the World’s Best Management Consulting Firms by Forbes
Alira Health is proud to announce it has been named by Forbes as one of the World’s Best Management Consulting Firms for 2023.
Life Sciences MedTech Pharma Press Release
Publications August 1, 2023
The EU Pharmaceutical Package: Impact on Orphan Medicinal Products
This article reviews the proposed changes in the EU Pharma Package for data protection related to orphan medicinal products (OMPs).
EU Pharma Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.